digoxigenin has been researched along with Substance Withdrawal Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, X; Ma, L; Yue, W; Zhang, J; Zhang, X | 1 |
| Banks, WA; Cohn, CS; Kastin, AJ; Plotkin, SR | 1 |
2 other study(ies) available for digoxigenin and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Acute and chronic morphine treatments and morphine withdrawal differentially regulate GRK2 and GRK5 gene expression in rat brain.
Topics: Analgesics, Opioid; Animals; beta-Adrenergic Receptor Kinases; Brain Chemistry; Cyclic AMP-Dependent Protein Kinases; Digoxigenin; G-Protein-Coupled Receptor Kinase 2; G-Protein-Coupled Receptor Kinase 5; In Situ Hybridization; In Vitro Techniques; Male; Morphine; Oligonucleotide Probes; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance Withdrawal Syndrome | 2002 |
Withdrawal from alcohol in withdrawal seizure-prone and -resistant mice: evidence for enkephalin resistance.
Topics: Aluminum; Animals; Brain Chemistry; Central Nervous System Depressants; Digoxigenin; Enkephalin, Methionine; Enkephalins; Ethanol; Female; Half-Life; Mice; Mice, Inbred Strains; MSH Release-Inhibiting Hormone; Neuropeptides; Protein Precursors; Radioimmunoassay; RNA, Messenger; Seizures; Substance Withdrawal Syndrome | 2001 |